| J01CR02 |
Amoxicilline, clavulanic acid |
MEDOCLAV 500 mg/125 mg |
Film coated tablet |
625 |
mg |
16 |
Medochemie Ltd., Кипър |
1000 |
mg amoxicilin |
- |
13.66 |
0.87875 |
7.03 |
25% |
1.76 |
J03 - до 18 години |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-4099/10.07.2014; НСР-4100/10.07.2014; НСР-4526/22.08.2014 |
16.09.2014 |
08.09.2012 |
|
Заличен |
2977 |
| J01CR02 |
Amoxicillin and enzyme inhubitor |
J01CR02 Amoxicillin and enzyme inhubitor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01CR02 |
Amoxicilline, clavulanic acid |
Amoksiklav |
Powder for oral suspension |
400 mg/57 mg/5 ml - 70 ml |
mg |
1 |
Lek Pharmaceuticals d.d., Словения |
1000 |
mg amoxicilin |
- |
5.87 |
1.04821 |
5.87 |
25% |
1.47 |
за деца до 8 години |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
КЦРР-758/07.06.2012 г.; НСР-1532/25.10.2013; НСР-2251/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
2213 |
| J01CR02 |
Amoxicilline, clavulanic acid |
AMOKSIKLAV |
Powder for oral suspension |
125 mg/31,25 mg/5 ml - 100 ml |
mg |
1 |
Lek Pharmaceuticals d.d., Словения |
1000 |
mg amoxicilin |
- |
5.3 |
1.04821 |
2.62 |
25% |
0.66 |
за деца до 8 години |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
№ 12/16,06,2009; КЦРР-758/07.06.2012 г.; НСР-2252/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
1253 |
| J01CR02 |
Amoxicilline, clavulanic acid |
MEDOCLAV |
Powder for oral suspension |
125 mg/31,25 mg/5 ml - 100 ml |
mg |
1 |
Medochemie Ltd., Кипър |
1000 |
mg amoxicilin |
- |
6.14 |
1.828 |
4.57 |
25% |
1.14 |
за деца до 8 години |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-3828/16.06.2014 |
16.07.2014 |
08.09.2012 |
|
Заличен |
1247 |
| J01CR02 |
Amoxicilline, clavulanic acid |
MEDOCLAV FORTE |
Powder for oral suspension |
250 mg/62.5/5 ml - 100 ml |
mg |
1 |
Medochemie Ltd., Кипър |
1000 |
mg amoxicilin |
- |
9.98 |
1.996 |
9.98 |
25% |
2.5 |
за деца до 8 години |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
КЦРР-758/07.06.2012 г.; НСР-4100/10.07.2014; НСР-4526/22.08.2014 |
16.09.2014 |
08.09.2012 |
|
Заличен |
2978 |
| J01CR04 |
Sultamicillin (Ampicillin; Sulbactam) |
J01CR04 Sultamicillin (Ampicillin; Sulbactam) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01CR04 |
Sultamicillin (Ampicillin, Sulbactam) |
Unasyn |
Film coated tablet |
375 |
mg |
12 |
Pfizer Europe MA EEIG, Обединено Кралство |
1 |
mg |
- |
15.16 |
0.00337 |
15.17 |
25% |
3.79 |
|
H66.0,J03,J15,J16,J40,J42,N10,N11 |
КЦРР-1907/15.12.2012 |
14.01.2013 |
08.09.2012 |
|
Заличен |
654 |
| J01DB01 |
Cefalexin |
J01DB01 Cefalexin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DB01 |
Cefalexin |
Ospexin |
Granules for oral suspension |
250 mg/5 ml - 60 ml |
mg |
1 |
Sandoz GmbH, Австрия |
2000 |
mg |
- |
4.3 |
2.86667 |
4.3 |
25% |
1.08 |
за деца до 8 години |
A38,H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,K12.0,K12.1,N10,N11.0,N11.1,N11.8 |
НСР-2281/13.01.2014 |
16.02.2014 |
08.09.2012 |
|
Заличен |
526 |
| J01DB05 |
Cefadroxil |
J01DB05 Cefadroxil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DB05 |
Cefadroxil |
DURACEF |
Capsule, hard |
500 |
mg |
12 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
2000 |
mg |
- |
7.31 |
2.43667 |
7.31 |
25% |
1.83 |
|
A38,H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-944/12.08.2013; НСР-6241/21.05.2015 |
16.06.2015 |
08.09.2012 |
|
Заличен |
4021 |
| J01DB05 |
Cefadroxil |
Valdocef |
Capsule, hard |
500 |
mg |
16 |
Alkaloid – INT d.o.o., Словения |
2000 |
mg |
- |
12.5 |
2.43667 |
9.75 |
25% |
2.44 |
|
A38,H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-2905/05.03.2014; НСР-5338/18.12.2014. |
16.01.2015 |
|
|
Заличен |
2563 |
| J01DB05 |
Cefadroxil |
J01DB05 Cefadroxil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DB05 |
Cefadroxil |
Biodroxil |
Powder for oral suspension |
250 mg/ 5 ml - 60 ml |
mg |
1 |
Sandoz GmbH, Австрия |
2000 |
mg |
- |
6.47 |
4.31333 |
6.47 |
25% |
1.62 |
за деца до 8 г. |
A38,H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-1930/27.11.2013; НСР-2282/13.01.2014 |
16.02.2014 |
08.09.2012 |
|
Заличен |
2327 |
| J01DB05 |
Cefadroxil |
Valdocef |
Granules for oral suspension |
250 mg/5 ml |
mg |
1 x 100 ml |
Alkaloid – INT d.o.o., Словения |
2000 |
mg |
- |
10.2 |
4.08 |
10.2 |
25% |
2.55 |
за деца до 8 г. |
J03.0,J03.8,J03.9,N10,N11.0,N11.1,N11.8 |
НСР-4724/26.09.2014; НСР-5348/18.12.2014. |
16.01.2015 |
|
|
Заличен |
3173 |
| J01DC02 |
Cefuroxime |
J01DC02 Cefuroxime |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DC02 |
Cefuroxime |
AKSEF |
Film coated tablet |
500 |
mg |
20 |
Нобел Фарма ЕООД, България |
500 |
mg |
- |
23.72 |
1.186 |
23.72 |
25% |
5.93 |
|
N10,N11.0,N11.1,N11.8 |
НСР-12714/19.05.2017(допуска предварително изпълнение); НСР-18086/01.03.2019 |
02.04.2019 |
|
|
Заличен |
3152 |
| J01DC02 |
Cefuroxime |
AKSEF 500 |
Film coated tablet |
500 |
mg |
20 |
Нобел Фарма ЕООД, България |
500 |
mg |
- |
23.72 |
1.186 |
23.72 |
25% |
5.93 |
|
N10,N11.0,N11.1,N11.8 |
№ 25/ 03.08.2009; № 29/ 10.08.2009; № 141/ 24.01.2011; КЦРР-1334/24.08.2012 г.; КЦРР-1976/10.01.2013 г; НСР-4449/15.08.2014; HCP-9250/05.05.2016; НСР-12231/03.04.2017 |
02.05.2017 |
08.09.2012 |
|
Заличен |
3152 |
| J01DC02 |
Cefuroxime |
Lifurox |
Film coated tablet |
500 |
mg |
10 |
Чайкафарма Висококачествените лекарства АД, България |
500 |
mg |
- |
23.72 |
1.186 |
11.86 |
25% |
2.96 |
|
N10,N11.0,N11.1,N11.8 |
№ 177/ 21.06.2011; КЦPP-582/04.05.2012 г.; HCP-9249/05.05.2016; НСР-16409/09.08.2018; НСР-18087/01.03.2019 |
02.04.2019 |
08.09.2012 |
|
Заличен |
909 |
| J01DC02 |
Cefuroxime |
Lifurox |
Film coated tablet |
250 |
mg |
10 |
Чайкафарма Висококачествените лекарства АД, България |
500 |
mg |
- |
18.6 |
1.186 |
5.93 |
25% |
1.48 |
|
N10,N11.0,N11.1,N11.8 |
№ 145/ 28.01.2011; КЦPP-582/04.05.2012 г.; HCP-9249/05.05.2016; НСР-12161/27.03.2017 |
02.05.2017 |
08.09.2012 |
|
Заличен |
908 |
| J01DC04 |
Cefaclor |
J01DC04 Cefaclor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DC04 |
Cefaclor |
CEFACLOR ALKALOID |
Capsule, hard |
500 |
mg |
16 |
Алкалоид ЕООД, България |
1000 |
mg |
- |
23.33 |
2.91625 |
23.33 |
25% |
5.83 |
|
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-7279/29.10.2015 |
02.12.2015 |
08.09.2012 |
|
Заличен |
110 |
| J01DC04 |
Cefaclor |
MEDOCLOR |
Capsule, hard |
500 |
mg |
16 |
Medochemie Ltd., Кипър |
1000 |
mg |
- |
22.4 |
2.8 |
22.4 |
25% |
5.6 |
|
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-3666/06.06.2014; НСР-4518/22.08.2014 |
16.09.2014 |
08.09.2012 |
|
Заличен |
2885 |
| J01DC04 |
Cefaclor |
MEDOCLOR |
Capsule, hard |
250 |
mg |
16 |
Medochemie Ltd., Кипър |
1000 |
mg |
- |
11.1 |
2.57 |
10.28 |
25% |
2.57 |
|
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-3472/16.05.2014 |
16.06.2014 |
08.09.2012 |
|
Заличен |
466 |